Spotlight -

Drug Development|

Quality Systems

J.P. Bercu

J.P. Bercu is senior director in nonclinical safety and pathobiology, Gilead Sciences.

Articles by J.P. Bercu

PAULISTA - STOCK.ADOBE.COM

Managing the Risk of Nitrosamine Impurities

ByTimothy Curran,J.P. Bercu

March 15th 2021

Latest Updated Articles

Managing the Risk of Nitrosamine Impurities
March 15th 2021

Trending on Pharmaceutical Technology

Pharma's AI ROI Problem Isn't a Tech Problem but a Qualification Problem

Inside Halo’s New Fill-Finish Platform

Q&A: AI Coding Tools Carry the Real Risk

Danish Biotechs Attracting Investor Attention

Alvelestat Deal Signals Early Manufacturing Push for AATD-LD